Nucleon Nutrition PT-141 10 mg nasal spray

Product guide · Restricted substance

Nucleon Nutrition PT-141 10 mg peptide nasal spray

Nucleon Nutrition

Peptide product from Nucleon Nutrition, spray. This guide sets out what the manufacturer states about the composition of Nucleon Nutrition PT-141 10 mg peptide nasal spray, what independent research says about its main ingredient, and the safety and regulatory points that apply. It contains substances that are not authorised as food or medicine in the EU. This guide is educational: it does not recommend use and gives no directions for use.

Educational guide · Sources checked 4 November 2026 · 6 references

Back to the product
Named ingredients
1
Amounts stated
All
Status
Restricted substance
Evidence summaries
1

Overview

Manufacturer information

Nucleon Nutrition PT-141 10 mg peptide nasal spray contains PT-141 (bremelanotide): 10 mg per bottle.

Ingredients & composition

Manufacturer information
IngredientAmount
PT-141 (bremelanotide)10 mg per bottle

Scientific background

Independent research

PT-141 (bremelanotide)

PT-141 (bremelanotide) is a melanocortin receptor agonist related to melanotan II. It was developed as a prescription medicine for low sexual desire1.

Research evidence

Independent research

PT-141 (bremelanotide)

Bremelanotide was evaluated in two phase 3 trials (RECONNECT) in premenopausal women with hypoactive sexual desire disorder1. An independent re-analysis concluded that its benefits were statistically modest2.

Evidence limitations

Independent research

No published study has tested this specific product; the research summarised here concerns the ingredient itself.

PT-141 (bremelanotide)

The trial evidence applies to the licensed medicine under medical supervision in a specific group; it does not apply to research-grade nasal sprays or injections2.

Safety & potential risks

Independent research

PT-141 (bremelanotide)

As a melanocortin agonist it can affect blood pressure and cause nausea and flushing; products sold for research are not quality-controlled3.

Regulatory status

GIGACULT product information

PT-141 (bremelanotide) is supplied as a peptide nasal spray. It is not a food or food supplement and is not an authorised medicinal product in the EU. No dosing information for human use is provided.

Regulation and sport

PT-141 (bremelanotide)

PT-141 sold for research use is not authorised as a medicine or as a food in the EU45. The World Anti-Doping Agency prohibits non-approved substances and peptide hormones, growth factors and related substances at all times6.

Scientific references

  1. Simon JA, Kingsberg SA, Portman D, et al. Prespecified and integrated subgroup analyses from the RECONNECT phase 3 studies of bremelanotide. J Womens Health (Larchmt). 2022;31:391-400. PubMed 35230162
  2. Spielmans GI, Ellefson EM. Small effects, questionable outcomes: bremelanotide for hypoactive sexual desire disorder. J Sex Res. 2024;61:540-561. PubMed 36809187
  3. Mendias CL, Awan TM. Safety and efficacy of approved and unapproved peptide therapies for musculoskeletal injuries and athletic performance. Sports Med. 2026;56:1921-1935. PubMed 41966639
  4. Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union. Source
  5. Regulation (EU) 2015/2283 on novel foods. Official Journal of the European Union. Source
  6. World Anti-Doping Agency. The Prohibited List (current edition). Source

Sources checked against PubMed, Crossref or the official publisher on 2026-11-04. Manufacturer information is taken from the product's own data and has not been independently tested.

The product

Nucleon Nutrition PT-141 10 mg peptide nasal spray

€44,90

View product